SEC Form 4 · accession 0001179110-18-005873
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jaime Contreras
Officer — Senior Vice President
Period of report
Apr 23, 2018
Accepted (ET)
Apr 25, 2018 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF3 | Apr 23, 2018 | S | 849 | $59.36 | D | 2,595 | I | By Spouse |
| Common shares without par value | holding | — | — | — | 50,436 | D | ||
| Common shares without par valueF1 | holding | — | — | — | 22 | I | Profit Sharing Trust | |
| Common shares without par valueF2 | holding | — | — | — | 64,297 | I | Jaime Contreras Marvan 2006 Living Trust | |
| Common shares without par valueF4 | holding | — | — | — | 12,081 | I | Living Trust (by spouse) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2018.
- F2Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
- F3The reporting person disclaims beneficial ownership of all securities held by his spouse.
- F4Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
Remarks
The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).